Insider · CIK 0001820187

Walker Marlan D

Reports to the SEC for 1 company · BOCA RATON, FL

sec.gov

Transactions

Companies

Filings

CIK

0001820187

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-03	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+67.5K sh	—	—	67,492
2025-04-14	TXMDTherapeuticsMD, Inc.P Purchase	Chief Executive Officer	PPurchase	+490 sh	$1.00	+$489.265	73,639
2025-04-10	TXMDTherapeuticsMD, Inc.P Purchase	Chief Executive Officer	PPurchase	+1,167 sh	$0.86	+$1,000.352	73,149
2025-04-09	TXMDTherapeuticsMD, Inc.P Purchase	Chief Executive Officer	PPurchase	+1,136 sh	$0.87	+$993.659	71,982
2025-02-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+3,467 sh	—	—	66,032
2025-02-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+2,311 sh	—	—	68,343
2025-02-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+770 sh	—	—	69,113
2025-02-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,733 sh	—	—	70,846
2025-02-18	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−3,467 sh	—	—	0
2025-02-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−2,311 sh	—	—	0
2025-02-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−770 sh	—	—	0
2025-02-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,733 sh	—	—	1,733
2023-12-07	TXMDTherapeuticsMD, Inc.S Sale	Chief Executive Officer	SSale	−4,550 sh	$2.24	−$10.2K	62,565
2023-12-06	TXMDTherapeuticsMD, Inc.S Sale	Chief Executive Officer	SSale	−14.5K sh	$2.31	−$33.5K	67,115
2023-12-05	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+70K sh	—	—	81,615
2023-12-05	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−70K sh	—	—	0
2023-04-26	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,010 sh	—	—	14,041
2023-04-26	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,734 sh	—	—	12,307
2023-04-26	TXMDTherapeuticsMD, Inc.S Sale	Chief Executive Officer	SSale	−692 sh	$3.64	−$2,517.565	11,615
2023-04-26	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,010 sh	—	—	0
2023-04-26	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,734 sh	—	—	3,466
2023-04-12	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+3,030 sh	—	—	8,999
2023-04-12	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,010 sh	—	—	10,009
2023-04-12	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,734 sh	—	—	11,743
2023-04-12	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,734 sh	—	—	13,477
2023-04-12	TXMDTherapeuticsMD, Inc.S Sale	Chief Executive Officer	SSale	−1,170 sh	$3.65	−$4,275.531	12,307
2023-04-12	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−3,030 sh	—	—	0
2023-04-12	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,010 sh	—	—	0
2023-04-12	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,734 sh	—	—	3,466
2023-04-12	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,734 sh	—	—	3,466
2023-02-21	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	+70K sh	—	—	70,000
2022-12-08	TXMDTherapeuticsMD, Inc.G Gift	Chief Executive Officer	GGift	−716 sh	—	—	5,969
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,010 sh	—	—	6,189
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+1,156 sh	—	—	7,345
2022-12-06	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+388 sh	—	—	7,733
2022-12-06	TXMDTherapeuticsMD, Inc.S Sale	Chief Executive Officer	SSale	−1,048 sh	$4.95	−$5,184.98	6,685
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,010 sh	—	—	1,010
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−1,156 sh	—	—	2,311
2022-12-06	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−388 sh	—	—	770
2022-03-31	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Executive Officer	AAward	+260K sh	—	—	260,000
2022-03-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	+260K sh	—	—	260,000
2022-03-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	+260K sh	—	—	260,000
2022-03-14	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+230K sh	—	—	258,908
2022-03-14	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−230K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	+57.8K sh	—	—	57,797
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Chief Executive Officer	JOther	−100K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Chief Executive Officer	JOther	−150K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Chief Executive Officer	JOther	−25K sh	—	—	0
2021-09-29	TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)J Other	Chief Executive Officer	JOther	−120K sh	—	—	0
2021-07-01	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Executive Officer	AAward	+347K sh	—	—	346,667

Recent filings

Accepted (ET)
Nov 54
Walker Marlan D0000905148-25-003782
SEC(opens sec.gov)
Apr 154
Walker Marlan D0000905148-25-001215
SEC(opens sec.gov)
Apr 104
Walker Marlan D0000905148-25-001190
SEC(opens sec.gov)
Feb 204
Walker Marlan D0000905148-25-000737
SEC(opens sec.gov)
Dec 74
Walker Marlan D0001209191-23-057725
SEC(opens sec.gov)
May 44/A
Walker Marlan D0001209191-23-027361
SEC(opens sec.gov)

Companies

TherapeuticsMD, Inc.Chief Executive OfficerTXMD

Address

951 YAMATO ROAD SUITE 220

BOCA RATON, FL, 33431